New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-Dna
Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40008
Full Text
Open PDFAbstract
Available in full text
Date
February 27, 2017
Authors
Publisher
Wiley